Major asthma guideline update: ICS-LABA as-needed replaces albuterol
www.pulmccm.org
In their first major update in 30 years, newly published asthma guidelines recommend significant changes to the way physicians treat millions of patients diagnosed with asthma. The Global Initiative for Asthma (GINA) now advises that, in general: Most people with asthma can now be prescribed just one inhaler: an inhaled corticosteroid-and-long-acting beta agonist (ICS-LABA) combination product, to be used as both a maintenance (preventive) and rescue inhaler.
Major asthma guideline update: ICS-LABA as-needed replaces albuterol
Major asthma guideline update: ICS-LABA…
Major asthma guideline update: ICS-LABA as-needed replaces albuterol
In their first major update in 30 years, newly published asthma guidelines recommend significant changes to the way physicians treat millions of patients diagnosed with asthma. The Global Initiative for Asthma (GINA) now advises that, in general: Most people with asthma can now be prescribed just one inhaler: an inhaled corticosteroid-and-long-acting beta agonist (ICS-LABA) combination product, to be used as both a maintenance (preventive) and rescue inhaler.